Literature DB >> 31090307

[Determination of plasma protein binding rates of nine compounds of Inula cappa extraction based on method of equilibrium dialysis].

Hong-Song Bao1, Jing-Yu Hou2, He-Jia Hu2, Yue-Ting Li2, Lin Zheng2, Yong Huang2, Guang-Cheng Wang2, Meng Zhou2, Yan-Yu Lan2, Zi-Peng Gong2.   

Abstract

To determine the plasma protein binding rate of the nine compounds in Inula cappa extraction by the method of equilibrium dialysis. The proteins in plasma samples were precipitated by methanol, and the ultra-performance liquid chromatography-tandem mass spectrometry(UPLC-MS/MS) was developed for determination of the concentrations of the nine active compounds, namely chlorogenic acid, scopolin, neochlorogenic acid, cryptochlorogenic acid, 1,3-O-dicaffeoylquinic acid, galuteolin, 3,4-O-dicaffeoylquinic acid, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, with the internal standard of puerarin. We found that all components have a good linearity(r≥0.999), and accuracy, precision, extraction recovery and stability conformed to the requirements of determination, without endogenous compounds disturbing within the range of optimum concentration. This suggested that the method was stable and reliable, and could be used for the determination of the plasma protein binding rates of the nine active compounds in rat and human plasma of I. cappa. The plasma protein binding rates of the nine active compounds in rat and human plasma respectively were(41.07±0.046)%-(94.95±0.008)%, and(37.66±0.043)%-(97.46±0.013)%. According to the results, there were differences in the plasma protein binding rates of the nine compounds in I. cappa extraction between rat and human.

Entities:  

Keywords:  Inula cappa; caffeoylquinic acid; equilibrium dialysis; plasma protein binding rates

Mesh:

Substances:

Year:  2019        PMID: 31090307     DOI: 10.19540/j.cnki.cjcmm.20190116.007

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Comparative pharmacokinetic study of the five anti-inflammatory active ingredients of Inula cappa in a normal and an LPS-induced inflammatory cell model.

Authors:  Jing Huang; Ruixing Chen; Jie Zhou; Qing Zhang; Cun Xue; Yueting Li; Lin Zheng; Yong Huang; Qun Wang; Yi Chen; Zipeng Gong
Journal:  Front Pharmacol       Date:  2022-09-19       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.